Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $164.20M | $115.24M | $79.76M | $81.10M | $78.63M | $79.53M | $94.93M | $95.35M |
| Cost of revenue | $94.16M | $85.14M | $59.01M | $77.20M | $73.60M | $71.31M | $90.16M | $95.51M |
| Gross profit | $70.04M | $30.11M | $20.76M | $3.91M | $5.03M | $8.21M | $4.76M | −$156.00K |
| Gross margin | 42.7% | 26.1% | 26.0% | 4.8% | 6.4% | 10.3% | 5.0% | -0.2% |
| Research and development | $0 | $0 | $0 | $0 | $0 | $0 | $11.83M | $0 |
| Selling, general and administrative | $76.43M | $44.85M | −$11.63M | $69.35M | $56.94M | $32.29M | $31.76M | $40.35M |
| Operating expenses | $127.74M | $327.39M | $107.82M | $84.43M | $27.14M | $55.25M | $41.52M | $40.70M |
| Operating income | −$57.70M | −$297.28M | −$87.07M | −$80.52M | −$22.12M | −$47.03M | −$36.76M | −$40.86M |
| Operating margin | -35.1% | -258.0% | -109.2% | -99.3% | -28.1% | -59.1% | -38.7% | -42.9% |
| EBITDA | −$254.00K | −$13.65M | −$56.75M | −$54.52M | −$3.36M | −$27.30M | −$12.79M | −$14.57M |
| Interest income | $0 | $0 | −$916.00K | $821.00K | $0 | $0 | $35.93M | −$7.07M |
| Interest expense | −$23.83M | −$4.86M | $0 | $0 | $1.19M | $2.19M | −$37.07M | $0 |
| Income before taxes | −$1.15B | −$346.59M | $216.05M | −$143.90M | −$936.64M | $576.46M | −$290.77M | −$455.13M |
| Income taxes | $1.91M | $600.00K | $95.00K | $125.00K | $158.00K | $205.00K | $375.00K | $134.00K |
| Net income | −$1.16B | −$347.19M | $215.96M | −$144.03M | −$936.80M | $576.25M | −$291.15M | −$455.26M |
| Net margin | -703.6% | -301.3% | 270.8% | -177.6% | -1191.4% | 724.6% | -306.7% | -477.4% |
| EPS, basic | −$3.32 | −$1.06 | $0.59 | −$0.45 | −$0.04 | $1.42 | −$0.65 | −$1.17 |
| EPS, diluted | −$3.32 | −$1.06 | $0.70 | −$0.45 | −$0.04 | $1.24 | −$0.78 | −$1.17 |
| Diluted shares | 325.33M | 322.91M | 272.41M | 318.56M | 317.99M | 363.31M | 269.81M | 292.49M |
Figures describe Core Scientific shares, not any token. As of Jul 28, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.